1 min read
Eli Lilly Study Finds Weight Reductions in Adolescents With Zepbound
Participants had obesity or excess weight and related health conditions.

A study of Eli Lilly’s Zepbound found weight reductions among adolescent participants.
Participants were adolescents with obesity or excess weight who had related health conditions.
The study examined Zepbound, also known as tirzepatide.